rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

GlaxoSmithKline Pharmaceuticals Ltd.

500660 GLAXO Group (A)

04 Nov,15:29
2644.50
-85.20 (-3.12%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL
3,497 2,729.70 2,729.70 - 2,602.00 3,087.95 - 1,387.90 44,797.84
NSE | BSE

GlaxoSmithKline Pharmaceuticals Ltd.

GLAXO

04 Nov,15:59
2624.90
-108.20 (-3.96%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL
143,629 2733.10 2,733.10 - 2,601.10 3,088.00 - 1,385.05 379,480,744.61
(Rs. Crore)

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,407.253,216.343,217.513,193.733,224.68
Operating profit900.65799.41755.83694.95658.45
Interest1.801.811.993.536.34
Gross profit1,022.33899.12830.06801.61729.67
EPS (Rs)34.5135.8799.7921.116.50

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

Royal Enfield...
Royal Enfield Unveils Electric Bike Flying Flea C6 - 2026 Release
Royal Enfield enters the electric bike segment with the Flying Flea C6, a classic-styled model set to launch in 2026. Learn about their new EV brand, development, and future plans.
Nov 04, 2024 23:51
Sagility India...
Sagility India IPO: Rs 945 Cr Anchor Investor Funding
Sagility India, a healthcare tech services provider, raised Rs 945 crore from anchor investors ahead of its IPO, which opens on November 5th.
Nov 04, 2024 22:28
Sebi Demands Rs...
Sebi Demands Rs 130 Crore from 5 Entities in Reliance Home Fin Case
Sebi has issued demand notices to five entities, including Netizen Engineering and Citi Securities, for Rs 130 crore in connection with the illegal diversion of funds from Reliance Home Finance.
Nov 04, 2024 22:03
Suzuki Unveils...
Suzuki Unveils First Electric SUV: e Vitara
Suzuki launches its first mass-production battery electric vehicle, the e Vitara, in Europe. Production is set to begin in India in 2025 with global sales planned.
Nov 04, 2024 21:26
In-flight WiFi...
In-flight WiFi Access: New Rules Clarify Device Usage
India's new aviation rules clarify that in-flight WiFi is only available when electronic devices are permitted. Learn about the new regulations and their impact on passenger connectivity.
Nov 04, 2024 19:54

More News »

Top News

Royal Enfield...
Royal Enfield Unveils Electric Bike Flying Flea C6 - 2026 Release
Royal Enfield enters the electric bike segment with the Flying Flea C6, a classic-styled model set to launch in 2026. Learn about their new EV brand, development, and future plans.
Nov 04, 2024 23:51
Sagility India...
Sagility India IPO: Rs 945 Cr Anchor Investor Funding
Sagility India, a healthcare tech services provider, raised Rs 945 crore from anchor investors ahead of its IPO, which opens on November 5th.
Nov 04, 2024 22:28
Sebi Demands Rs...
Sebi Demands Rs 130 Crore from 5 Entities in Reliance Home Fin Case
Sebi has issued demand notices to five entities, including Netizen Engineering and Citi Securities, for Rs 130 crore in connection with the illegal diversion of funds from Reliance Home Finance.
Nov 04, 2024 22:03
Suzuki Unveils...
Suzuki Unveils First Electric SUV: e Vitara
Suzuki launches its first mass-production battery electric vehicle, the e Vitara, in Europe. Production is set to begin in India in 2025 with global sales planned.
Nov 04, 2024 21:26
FSIB Recommends Rahul Bhave for IFCI MD Post
FSIB has recommended Rahul Bhave, currently Deputy Managing Director of IFCI, for the position of Managing Director and CEO of IFCI Ltd. The final decision will be taken by the Appointments...
Nov 04, 2024 21:14

More Top News »

Report Card

PE Ratios
76.62
EPS (Rs.)
34.51
Sales (Rs. Cr)
1,000.05
Face Value (Rs.)
10
Net Profit Margin (%)
17.16
Last Bonus
1:1
Last Dividend(%)
120
Return on Average Equity
32.6

BSE Announcements from GlaxoSmithKline Pharmaceuticals Ltd. (See all)

announcement Announcement Under Regulation 30: Updates - 1 day(s) ago
announcement Corporate Action- Record Date For Special Interim Dividend - 1 day(s) ago

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,858.70
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,207.70
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,004.00
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,036.65
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,006.75
  • Compare
  • Divi's Laboratories Ltd.
  • 5,901.00
  • Compare
  • Alkem Laboratories Ltd.
  • 5,807.75
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Sir,A person sec 44ad provision itr filed.but...

Myself 55 years old,, i am going to acquire a...

Hi I am 44 years old and have 5 cr in FD,s , 1.5 cr...

hello Sir! good day. I was an NRI for 14 years...

Sir My age is 53. My PF contribution from salary is...

Hello, I plan to generate wealth on longterm for...

More REDIFFGURUS

RediffGurus

Money question

Hello Sir, I plan to invest in the following funds...

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
GlaxoSmithKline Pharmaceuticals Ltd.
Share Price » Fundamentals » Financial » Technicals » Screener » Open Demat »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close